Type 1 Diabetes
Studies from A.R. Chacra and co-researchers update current data on type 1 diabetes
Published in Obesity and Diabetes Week, June 7th, 2010
"The efficacy of two basal insulins, insulin lispro protamine suspension (ILPS) and insulin detemir, was compared in basal-bolus regimens in Type 1 diabetes. In this 32-week, multinational, parallel-group, randomized, controlled trial, adult patients with Type 1 diabetes received ILPS or insulin detemir, injected twice daily (before breakfast and bedtime) and prandial insulin lispro three times daily," investigators in the United States report.
"The primary outcome was change in glycated haemoglobin (HbA(1c)) from baseline to endpoint. Least squares mean (+/- se) changes in HbA(1c) were similar between groups, meeting non-inferiority (margin, 0.4%): -0.69 +/- 0.07% for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Hypertension
American Heart Association Rapid Access Journal Report: Frequent Doctor Visits Help Diabetics Lower Blood Pressure More Quickly - Dementia
Data from University of Massachusetts advance knowledge in dementia - Hemodynamics
Data on hemodynamics discussed by M.E. Keramidas and colleagues - Type 2 Diabetes
Data on type 2 diabetes described by R. Pencek et al - Type 2 Diabetes
Data on type 2 diabetes detailed by L. Zhang and co-authors - Type 2 Diabetes
Data on type 2 diabetes discussed by S. Sarwat and colleagues - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
